Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distreptaza for pelvic inflammatory disease-associated pelvic pain
IRCT20091012002576N52Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in Pelviabdominal infection comparing Distreptaza + standard antibiotics with Placebo + standard antibiotics (2 arms). Primary endpoint: Adhesions in transvaginal sonogram. Started Oct 2024; status: completed.
02
Drugs
streptokinase + streptodornase
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on IRCT20091012002576N52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N52.